Aggregation – Dependent Effects of Wild-Type and Mutant α-Synuclein on Synaptic Membrane Fusion
Objective: 1. What is the endogenous form of ⍺-Synuclein in various cell types?2. How do WT ⍺-Synuclein monomer and aggregates affect presynaptic membrane fusion and the…Detection of α-synuclein seeds in skin samples from PPMI participants
Objective: To evaluate the presence of α-synuclein seeds (syn-seeds) in skin samples from PPMI participants, including prodromal, early and late Parkinson’s disease (PD) using a…Disparate Subregional Striatal DAT-SPECT Associations with CSF-Synucleinopathy Status and Clinical Severity Across Parkinson’s Disease Continuum
Objective: To determine the association between subregional DAT binding ratios (SBRs) for disease risk, PD progression, and whether these associations differ based on SAA status.…Screening the Neuroprotective Potential of Mushroom Extracts in In Vitro Models of Parkinson’s Disease
Objective: This study aimed to evaluate the neuroprotective potential of various mushroom extracts across four distinct cellular models of PD. Furthermore, we sought to identify…Bridging the Genomic Gap: Ancestry-Aware Polygenic Risk and Variant Discovery in African Parkinson’s Disease Cohorts
Objective: This study evaluates the shift from Euro-centric data to a diversified landscape. We aim to quantify the performance of European-derived Polygenic Risk Scores (PRS)…A Novel Genome Editing Strategy for Permanent and Precise Downregulation of α-Synuclein in Parkinson’s Disease
Objective: This work aims to develop and evaluate novel nonviral CRISPR-based genome editing strategies to achieve precise and durable transcriptional modulation of SNCA, enabling controlled…A CSF C Terminal α Synuclein Assay to Differentiate Multiple System Atrophy From Parkinson’s Disease
Objective: Differentiating MSA from PD is clinically challenging. We developed CSF assays to measure full length and major C‑terminally truncated α‑synuclein (αSyn) species for potential…A highly specific skin α-synuclein seed amplification assay for screening of synucleionpathies
Objective: To evaluate the performance of a skin α-synuclein seed amplification assay (skin_synSAA) as a screening test using samples from movement disorder subjects with uncertain…Genetic determinants of cognitive performance in Parkinson’s disease: impact of distal regulatory variation at the SNCA locus in the gp2 cohort
Objective: This study evaluates the association between a distal regulatory haplotype at the SNCA locus and cognitive performance, measured by the Montreal Cognitive Assessment (MoCA),…Multiplexed Serum Biomarkers for Differentiating the Parkinson’s Disease Continuum and Disease Severity
Objective: Reliable blood biomarkers for identifying the Parkinson’s disease (PD) spectrum and reflecting disease severity remain limited. We investigated whether multiple serum biomarkers could differentiate…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 70
- Next Page »
